Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Indian Journal of Surgical Oncology
Erschienen in: Indian Journal of Surgical Oncology 2/2019

18.03.2019 | Review Article

Assessment of Exocrine Function of Pancreas Following Pancreaticoduodenectomy

verfasst von: Kiran Thogari, Mallika Tewari, S. K. Shukla, S. P. Mishra, H. S. Shukla

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Pancreatic exocrine insufficiency (PEI) is a common long-term complication after pancreaticoduodenectomy (PD) and is observed in 23–80% of patients. As the postoperative mortality after PD has substantially decreased, it warrants more attention on the diagnosis and treatment of functional long-term consequences after PD. These include PEI and endocrine insufficiency that can result in significant nutritional impairment and often adversely impacts quality of life (QOL) of the patient. A PubMed search was performed for articles using key words “pancreatic exocrine insufficiency”; “pancreaticoduodenectomy”; “quality of life after pancreaticoduodenectomy”; “stool elastase”; “direct, indirect tests for pancreatic exocrine insufficiency”; “pancreatic enzyme replacement therapy.” Relevant studies were shortlisted and analyzed. This review summarizes relevant studies addressing PEI following PD. We also discuss functional changes after PD, risk factors and predictive factors for postoperative PEI, clinical symptoms, direct and indirect tests for estimation of PEI, pancreatic enzyme replacement therapy (PERT), and QOL after pancreatic resection for malignancy. It was found that significant PEI occurs in most patients following PD. Fecal elastase 1 is an easy indirect test and should be performed routinely in both symptomatic and asymptomatic patients after PD. PERT should be considered in every patient after PD with the aim to improve the QOL and perhaps even their long time survival.
Literatur
1.
Dominguez-Munoz JE (2007) Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep 9:116–122CrossRefPubMed
2.
Tseng et al (2016) Pancreatic exocrine insufficiency in patients with pancreatic or periampullary cancer: a systematic review. Pancreas 45:325–330CrossRef
3.
Bartel MJ et al (2015) Pancreatic exocrine insufficiency in pancreatic cancer. A review of the literature. Dig Liver Dis 47:1013–1020CrossRefPubMed
4.
Gullo L, Pezzilli R, Priori P, Baldoni F, Paparo F, Mattioli G (1987) Pure pancreatic juice collection over 24 consecutive hours. Pancreas. 2:620–623CrossRefPubMed
5.
Scheele G, Bartelt D, Bieger W (1981) Characterization of human exocrine pancreatic proteins by two-dimensional isoelectric focusing/sodium dodecyl sulfate gel electrophoresis. Gastroenterology. 80:461–473CrossRefPubMed
6.
Anagnostides A, Chadwick VS, Selden AC et al (1984) Sham feeding and pancreatic secretion. Evidence for direct vagal stimulation of enzyme output. Gastroenterology. 87:109–114CrossRefPubMed
7.
Perez MM, Newcomer AD, Moertel CG, Go VLW, Dimagno EP (1983) Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer. Cancer 52:346–352CrossRefPubMed
8.
Watanabe S, Shiratori K, Takeuchi T, Chey WY, You CH, Chang TM (1986) Release of cholecystokinin and exocrine pancreatic secretion in response to an elemental diet in human subjects. Dig Dis Sci 31:919–924CrossRefPubMed
9.
Guimbaud R, Moreau JA, Bouisson M, Durand S, Escourrou J, Vaysse N, Frexinos J (1997) Intraduodenal free fatty acids rather than triglycerides are responsible for the release of CCK in humans. Pancreas 14:76–82CrossRefPubMed
10.
Hildebrand P, Petrig C, Burckhardt B, Ketterer S, Lengsfeld H, Fleury A, Hadváry P, Beglinger C (1998) Hydrolysis of dietary fat by pancreatic lipase stimulates cholecystokinin release. Gastroenterology 114:123–129CrossRefPubMed
11.
Ghaneh P, Neoptolemos JP (1999) Exocrine pancreatic function following pancreatectomy. Ann N Y Acad Sci 880:308–318CrossRefPubMed
12.
van Berge Henegouwen MI, van Gulik TM et al (1997) Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients. J Am Coll Surg 185:373–379CrossRefPubMed
13.
Tran KT, Smeenk HG, van Eijck CH, Kazemier G et al (2004) Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240:738–745CrossRefPubMedPubMedCentral
14.
Shan YS, Sy ED, Tsai ML, Tang LY, Li PS, Lin PW (2005) Effects of somatostatin prophylaxis after pylorus-preserving pancreaticoduodenectomy: increased delayed gastric emptying and reduced plasma motilin. World J Surg 29:1319–1324CrossRefPubMed
15.
Kamiya T, Kobayashi Y, Hirako M, Misu N, Nagao T, Hara M, Matsuhisa E, Ando T, Adachi H, Sakuma N, Kimura G (2002) Gastric motility in patients with recurrent gastric ulcers. J Smooth Muscle Res 38:1–9CrossRefPubMed
16.
Kimura F, Suwa T, Sugiura T, Shinoda T, Miyazaki M, Itoh H (2002) Sepsis delays gastric emptying following pylorus-preserving pancreaticoduodenectomy. Hepatogastroenterology 49:585–588PubMed
17.
Tran TC, van Lanschot JJ, Bruno MJ, van Eijck CH (2009) Functional changes after pancreatoduodenectomy. Diagnosis and treatment. Pancreatology 9:729–737CrossRefPubMed
18.
DiMagno EP (1979) Medical treatment of pancreatic insufficiency. Mayo Clin Proc 54:435–442PubMed
19.
Layer P, Keller J (1999) Pancreatic enzymes, secretion and luminal nutrient digestion in health and disease. J Clin Gastroenterol 28:3–10CrossRefPubMed
20.
Lim P-W, Dinh KH, Sullivan M, Wahid Y et al (2016) Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection. HPB. 18:360–366CrossRefPubMedPubMedCentral
21.
Singh VK, Haupt ME, Geller DE, Hall JA, Diez PMQ (2017) Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol 23:7059–7076CrossRefPubMedPubMedCentral
22.
Yuasa Y, Murakami Y, Nakamura H, Uemura K, Ohge H, Sudo T, Hashimoto Y, Nakashima A, Hiyama E, Sueda T (2012) Histological loss of pancreatic exocrine cells correlates with pancreatic exocrine function after pancreatic surgery. Pancreas. 41:928–933CrossRefPubMed
23.
Sato N, Yamaguchi K, Yokohata K et al (1998) Short-term and long-term pancreatic exocrine and endocrine functions after pancreatectomy. Dig Dis Sci 43:2616–2621CrossRefPubMed
24.
Matsumoto J, Traverso LW (2006) Exocrine function following the Whipple operation as assessed by stool elastase. J Gastrointest Surg 10:1225–1229CrossRefPubMed
25.
Nakamura H, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T (2011) Reduced pancreatic parenchymal thickness indicates exocrine pancreatic insufficiency after pancreatoduodenectomy. J Surg Res 171:473–478CrossRefPubMed
26.
Andersen DK (2007) Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Pancreas. 35:1–15CrossRefPubMed
27.
McCallum LM, Lamarca A, Valle JW (2016) Prevalence of symptomatic pancreatic exocrine insufficiency in patients with pancreatic malignancy; nutritional intervention may improve survival. Cancer Res Front 2:352–367CrossRef
28.
Dumasy V, Delhaye M, Cotton F, Deviere J (2004) Fat malabsorption screening in chronic pancreatitis. Am J Gastroenterol 99:1350–1354CrossRefPubMed
29.
Lankisch PG, Droge M, Hofses S, Konig H, Lembcke B (1996) Steatorrhoea, you cannot trust your eyes when it comes to diagnosis. Lancet. 347:1620–1621CrossRefPubMed
30.
DiMagno EP, Go VL, Summerskill WH (1973) Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815CrossRefPubMed
31.
Layer P, von der Ohe MR, Holst JJ, Jansen JB, Grandt D, Holtmann G, Goebell H (1997) Altered postprandial, role of malabsorption. Gastroenterology 112:1624–1634CrossRefPubMed
32.
Dujsikova H, Dite P, Tomandl J, Sevcikova A, Precechtelova M (2008) Occurrence of metabolic osteopathy in patients with pancreatitis. Pancreatology 8:583–586CrossRefPubMed
33.
Haas S, Krins S, Knauerhase A, Lohr M (2015) Altered bone metabolism and bone density in patients with chronic pancreatitis and pancreatic exocrine insufficiency. JOP 16:58–62PubMed
34.
Mann ST, Mann V, Stracke H, Lange U, Klor HU, Hardt P et al (2008) Fecal elastase 1 and vitamin D3 in patients with osteoporotic bone fractures. Eur J Med Res 13:68–72PubMed
35.
Moran CE, Sosa EG, Martinez SM, Geldern P, Messina D, Russo A et al (1997) Bone mineral density in patients with pancreatic insufficiency and steatorrhea. Am J Gastroenterol 92:867–871PubMed
36.
Hart PA, Topazian M, Raimondo M, Cruz-Monserrate Z, Fisher WE, Lesinski GB, Steen H, Conwell DL (2016) Endoscopic pancreas fluid collection: methods and relevance for clinical care and translational science. Am J Gastroenterol 111:1258–1266CrossRefPubMedPubMedCentral
37.
Schlachterman F (2017) Pancreatic function testing for the early diagnosis of chronic pancreatitis. Gastrointest Endosc 86:1056–1058CrossRefPubMed
38.
Domínguez-Muñoz JE (2011) Pancreatic exocrine insufficiency, diagnosis and treatment. J Gastroenterol Hepatol 26:12–16CrossRefPubMed
39.
Tirkes T, Lin C, Fogel EL, Sherman SS, Wang Q, Sandrasegaran K (2017) T1 mapping for diagnosis of mild chronic pancreatitis. J Magn Reson Imaging 45:1171–1176CrossRefPubMed
40.
Katschinski M, Schirra J, Bross A, Goke B, Arnold R (1997) Duodenal secretion and fecal excretion of pancreatic elastase-1 in healthy humans and patients with chronic pancreatitis. Pancreas 15:191–200CrossRefPubMed
41.
Keller J, Aghdassi AA, Lerch MM, Mayerle JV, Layer P (2009) Tests of pancreatic exocrine function - clinical significance in pancreatic and non-pancreatic disorders. Best Pract Res Clin Gastroenterol 23:25–439
42.
Lara LF, Takita M, Burdick JS, DeMarco DC, Pimentel RR, Erim T, Levy MF (2017) A study of the clinical utility of a 20-minute secretin-stimulated endoscopic pancreas function test and performance according to clinical variables. Gastrointest Endosc 86:1048–1055CrossRefPubMed
43.
Keller J, Layer P (2015) Diagnosis of pancreatic exocrine insufficiency in chronic pancreatitis. Am Pancreat Assoc 1:1–7
44.
45.
Lankisch PG, Schreiber A, Otto J (1983) Pancreolauryl test. Evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function. Dig Dis Sci 28:490–493CrossRefPubMed
46.
Beharry S, Ellis L, Corey M, Marcon M, Durie P (2002) How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr 141:84–90CrossRefPubMed
47.
Nandhakumar N, Green MR (2010) Interpretations, how to use faecal elastase testing. Arch Dis Child Educ Pract Ed 95:119–123CrossRefPubMed
48.
Laser et al (1996) Faecal elastase 1, a novel, highly sensitive and specific pancreatic function test. Gut 39:580–586CrossRef
49.
Stein et al (1996) Faecal immunoreactive elastase 1: evaluation of a new tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function test. Clin Chem 42:222–226PubMed
50.
Katschinski et al (1997) Duodenal secretion and faecal excretion of pancreatic elastase 1 in healthy humans and patients with chronic pancreatitis. Pancreas 15:191–200CrossRefPubMed
51.
Walkowiak J, Herzig K-H, Strzykala K, Przyslawski J, Krawczynski M (2002) Fecal elastase-1 is superior to feacal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics 110:1–4CrossRef
52.
Glasbrenner B et al (1996) Clinical evaluation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis. Eur J Gastroenterol Hepatol 8:1117–1120CrossRefPubMed
53.
54.
Siegmund E, Lohr JM, Schuff-Werner P (2004) The diagnostic validity of non-invasive pancreatic function tests- a meta-analysis. Z Gastroenterol 42:1117–1128CrossRefPubMed
55.
Iglesias-Garcia J, Vilarino-Insua M, Iglesias-Rey M, Lourido V, Dominguez-Munoz E (2003) Accuracy of the optimized 13C-mixed triglyceride breath test for the diagnosis of steatorrhea in clinical practice. Gastroenterology 124:1CrossRef
56.
Keller J, Bruckel S, Jahr C, Layer P (2011) A modified 13C-mixed triglyceride breath test detects moderate pancreatic exocrine insufficiency. Pancreas 40:1201–1205CrossRefPubMed
57.
Keller J, Meier V, Wolfram KU, Rosien U, Layer P (2014) Sensitivity and specificity of an abbreviated 13C-mixed triglyceride breath test for measurement of pancreatic exocrine function. United European Gastroenterol J 2:288–294CrossRefPubMedPubMedCentral
58.
Dominguez-Munoz JE, Iglesias-Garcia J, Vilarino-Insua M, Iglesias-Rey M (2007) 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 5:484–488CrossRefPubMed
59.
Raman M, Fenton T, Crotty P, Ghosh S, Rioux K, Hundal R (2015) A novel method to identify fat malabsorption: the serum retinyl palmitate test. Clin Chim Acta 438:103–106CrossRefPubMed
60.
Dorsey J, Buckley D, Summer S et al (2010) Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid. J Pediatr Gastroenterol Nutr 50:441–446PubMedPubMedCentral
61.
Weintraub A, Blau H, Mussaffi H, Picard E, Bentur L, Kerem E, Stankiewicz H, Wilschanski M (2009) Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study. J Pediatr Gastroenterol Nutr 48:306–310CrossRefPubMed
62.
63.
Pedrazzoli S, Canton SA, Sperti C (2011) Duodenum-preserving versus pylorus-preserving pancreatic head resection for benign and premalignant lesions. J Hepatobiliary Pancreat Sci 18:94–102CrossRefPubMed
64.
Ohtsuka T, Tanaka M, Miyazaki K (2006) Gastrointestinal function and quality of life after pylorus-preserving pancreatoduodenectomy. J Hepato-Biliary-Pancreat Surg 13:218–224CrossRef
65.
66.
Howard JM, Hess W (2002) Tumors of the ampulla of Vater and pancreas. In: History of the pancreas. Mysteries of a hidden organ. Kluer Academic/Plenum Publishers, New York, pp 421–518
67.
68.
Watson AO (1944) Treatment of carcinoma of the ampulla of Vater: successful radical resection. Br J Surg 31:368–373CrossRef
69.
70.
Yamaguchi K, Yokohata K, Nakano K, Ohtani K, Ogawa Y, Chijiiwa K, Tanaka M (2001) Which is a less invasive pancreatic head resection: PD, PPPD, or DPPHR? Dig Dis Sci 46:282–288CrossRefPubMed
71.
Topal B, Fieuws S, Aerts R, Weerts J, Feryn T, Roeyen G, Bertrand C, Hubert C, Janssens M, Closset J (2013) Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy for pancreatic or periampullary tumours: a multicentre randomised trial. Lancet Oncol 14:655–662CrossRefPubMed
72.
He T, Zhao Y, Chen Q, Wang X, Lin H, Han W (2013) Pancreaticojejunostomy versus pancreaticogastrostomy after pancreaticoduodenectomy: a systematic review and meta-analysis. Dig Surg 30:56–69CrossRefPubMed
73.
Lemaire E, O’Toole D, Sauvanet A et al (2000) Functional and morphological changes in the pancreatic remnant following pancreaticoduodenectomy with pancreaticogastric anastomosis. Br J Surg 87:434–438CrossRefPubMed
74.
Nakamura H, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T (2009) Predictive factors for exocrine pancreatic insufficiency after pancreatoduodenectomy with pancreaticogastrostomy. J Gastrointest Surg 13:1321–1327CrossRefPubMed
75.
Jang JY, Kim SW, Park SJ et al (2002) Comparison of the functional outcome after pylorus-preserving pancreatoduodenectomy: pancreatogastrostomy and pancreatojejunostomy. World J Surg 26:366–371CrossRefPubMed
76.
Fogel MR, Gray GM (1973) Starch hydrolysis in man: an intraluminal process not requiring membrane digestion. J Appl Physiol 35:263–267CrossRefPubMed
77.
Halloran CM et al (2011) Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life. A prospective study. Pancreatology 11:535–545CrossRefPubMed
78.
79.
Sikkens ECM et al (2014) Prospective assessment of the influence of pancreatic cancer resection on exocrine pancreatic function. BJS 101:109–113CrossRef
80.
Beger HG, Poch B, Mayer B, Siech M (2017) New onset of diabetes and pancreatic exocrine insufficiency after pancreaticoduodenectomy for benign and malignant tumors. Ann Surg 20:1–16CrossRef
81.
Lyubimova NV, Kosyrev VY, Patyutko YI, Kushlinskii NE (2003) Analysis of elastase 1 for evaluation of excretory function of the pancreas after gastropancreatoduodenal resection. Bull Exp Biol Med 135:34–36CrossRefPubMed
82.
Pessaux P, Aube C, Lebigot J, Tuech JJ, Regenet N, Kapel N, Caron C, Arnaud JP (2002) Permeability and functionality of pancreaticogastrostomy after pancreaticoduodenectomy with dynamic magnetic resonance pancreatography after secretin stimulation. J Am Coll Surg 194:454–462CrossRefPubMed
83.
Mariani A, Mezzi G, Masci E, Soldarini A, Calori G, Zerbi A, Tittobello A (1999) Accuracy of the plasma amino acid-consumption test in detecting pancreatic diseases is due to different methods. Pancreas 18:203–211CrossRefPubMed
84.
Durie P, Baillargeon JD, Bouchard S et al (2018) Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel. Curr Med Res Opin 34:25–33CrossRefPubMed
85.
Hart PA, Conwell DL (2018) Challenges and updates in the management of exocrine pancreatic insufficiency. Pancreas 34:25–33
86.
Sabater L, Ausania F, Bakker OJ, Boadas J, Domínguez-Muñoz JE, Falconi M, Fernández-Cruz L, Frulloni L, González-Sánchez V, Lariño-Noia J, Lindkvist B, Lluís F, Morera-Ocón F, Martín-Pérez E, Marra-López C, Moya-Herraiz Á, Neoptolemos JP, Pascual I, Pérez-Aisa Á, Pezzilli R, Ramia JM, Sánchez B, Molero X, Ruiz-Montesinos I, Vaquero EC, de-Madaria E (2016) Evidence-based guidelines for the management of exocrine pancreatic insufficiency after pancreatic surgery. Ann Surg 264:949–958CrossRefPubMed
87.
Frulloni L, Falconi M, Gabbrielli A, Gaia E, Graziani R, Pezzilli R et al (2010) Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis 42:381–406CrossRef
88.
Layer P, Keller J, Lankisch PG (2001) Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep 3:101–108CrossRefPubMed
89.
Bruno MJ, Borm JJ, Hoek FJ, Delzenne B, Hofmann AF, de Goeij JJ et al (1997) Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy. Br J Surg 84:952–956CrossRefPubMed
90.
Domínguez-Muñoz JE (2009) Pancreatic enzyme replacement therapy, exocrine pancreatic insufficiency after gastrointestinal surgery. HPB. 11:3–6CrossRefPubMedPubMedCentral
91.
Kahl S, Malfertheiner P (2004) Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol 18:947–955CrossRefPubMed
92.
Ghaneh P, Neoptolemos JP (1999) Pancreatic exocrine insufficiency following pancreatic resection. Digestion. 60:104–110CrossRefPubMed
93.
Taylor M (2017) Nutritional and metabolic derangements in pancreatic cancer and pancreatic resection. Nutrients 9:243CrossRef
94.
Smith RC, Smith SF, Wilson J, Pearce C, Wray N, Vo R, Chen J, Ooi CY, Oliver M, Katz T, Turner R, Nikfarjam M, Rayner C, Horowitz M, Holtmann G, Talley N, Windsor J, Pirola R, Neale R (2016) Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology 16:164–180CrossRefPubMed
95.
Nguyen TC, Sohn TA, Cameron JL, Lillemoe KD, Campbell KA et al (2003) Standard vs radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg 7:1–9CrossRefPubMed
96.
Schniewind B, Bestmann B, Henne-Bruns D, Faendrich F, Kremer B, Kuechler T (2006) Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head. Br J Surg 93:1099–1107CrossRefPubMed
97.
Nieveen van Dijkum EJ, Kuhlmann KF, Terwee CB, Obertop H, de Haes JC, Gouma DJ (2005) Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg 92:471–477CrossRefPubMed
98.
Witzigmann H, Max D, Uhlmann D, Geissler F, Schwarz R, Ludwig S, Lohmann T, Caca K, Keim V, Tannapfel A, Hauss J (2003) Outcome after duodenum-preserving pancreatic head resection is improved compared with classic Whipple procedure in the treatment of chronic pancreatitis. Surgery 134:53–62CrossRefPubMed
Metadaten
Titel
Assessment of Exocrine Function of Pancreas Following Pancreaticoduodenectomy
verfasst von
Kiran Thogari
Mallika Tewari
S. K. Shukla
S. P. Mishra
H. S. Shukla
Publikationsdatum
18.03.2019
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 2/2019
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-019-00901-0

Weitere Artikel der Ausgabe 2/2019

Indian Journal of Surgical Oncology 2/2019 Zur Ausgabe

Original Article

Impact of Length of Distal Margin on Outcomes Following Sphincter Preserving Surgery for Middle and Lower Third Rectal Cancers

Original Article

Factors Predictive of Reoperation After Pancreaticoduodenectomy for Pancreatic Cancer

Original Article

A New Concept of Interval TRAM for Immediate Breast Reconstruction in Obese Women

Letter to the Editor

Cytologic Clues to the Diagnosis of Lymphoepithelioma-Like Carcinoma of Parotid Gland with Possible Therapeutic Implications

Case Report

Double Pyramidal Lobe of the Thyroid Gland a Rare Variation: Case Report

Case Report

Carotid Body Tumor Diagnosed by On-Site FNA: a Case Report

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.
Bildnachweise